Back to Search
Start Over
Actin- regulated Siglec- 1 nanoclustering influences HIV-1 capture and virus- containing compartment formation in dendritic cells
- Publication Year :
- 2023
-
Abstract
- The immunoglobulin-like lectin receptor CD169 (Siglec-1) mediates the capture of HIV- 1 by activated dendritic cells (DCs) through binding to sialylated ligands. These interactions result in a more efficient virus capture as compared to resting DCs, although the underlying mech- anisms are poorly understood. Using a combination of super-resolution microscopy, single-particle tracking and biochemical perturbations we studied the nanoscale organization of Siglec-1 on acti- vated DCs and its impact on viral capture and its trafficking to a single viral-containing compartment. We found that activation of DCs leads to Siglec-1 basal nanoclustering at specific plasma membrane regions where receptor diffusion is constrained by Rho-ROCK activation and formin-dependent actin polymerization. Using liposomes with varying ganglioside concentrations, we further demonstrate that Siglec-1 nanoclustering enhances the receptor avidity to limiting concentrations of gangliosides carrying sialic ligands. Binding to either HIV-1 particles or ganglioside-bearing liposomes lead to enhanced Siglec-1 nanoclustering and global actin rearrangements characterized by a drop in RhoA activity, facilitating the final accumulation of viral particles in a single sac-like compartment. Overall, our work provides new insights on the role of the actin machinery of activated DCs in regulating the formation of basal Siglec-1 nanoclustering, being decisive for the capture and actin-dependent traf- ficking of HIV-1 into the virus-containing compartment
Details
- Database :
- OAIster
- Notes :
- he research leading to these results has received funding from the European Commission H2020 Program (grant agreement ERC Adv788546 (NANO-MEMEC) (to MFG-P) and Marie Sklodowska-Curie grant 754558- PREBIST (to NM)), Government of Spain Severo Ochoa CEX2019-000910-S, State Research Agency (AEI) (PID2020- 113068RB- I00/10.13039/501100011033 (to MFG- P), PID2019- 109870RB- I00 (to JM- P), (PID2020- 117405GB-100 to ML), RYC-2017-22227 (to FC), RYC-2015-17896 (to CM), and PID2019- 106232RB-I00/10.13039/501100011033 (to FC)), Fundació CELLEX (Barcelona), Fundació Mir- Puig and the Generalitat de Catalunya through the CERCA program and AGAUR (Grant No. 2017SGR1000 to MFG-P). NI-U is supported by grant PID2020-117145RB-I00 from the Spanish Ministry of Science and Innovation. JM- P an NI- U are funded by the CIBER de Enfermedades Infecciosas., English
- Publication Type :
- Electronic Resource
- Accession number :
- edsoai.on1376895975
- Document Type :
- Electronic Resource